Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of VEGF gene polymorphisms and proliferative diabetic retinopathy in Mexican population.
Gonzalez-Salinas R, Garcia-Gutierrez MC, Garcia-Aguirre G, Morales-Canton V, Velez-Montoya R, Soberon-Ventura VR, Gonzalez V, Lechuga R, Garcia-Solis P, Garcia-Gutierrez DG, Garcia-Solis MV, Saenz de Viteri M, Solis-S JC. Gonzalez-Salinas R, et al. Int J Ophthalmol. 2017 Jan 18;10(1):135-139. doi: 10.18240/ijo.2017.01.22. eCollection 2017. Int J Ophthalmol. 2017. PMID: 28149790 Free PMC article.
[Mexican clinical experience in ocular anti-angiogenic therapy].
Quiroz-Mercado H, Vélez-Montoya R, Fromow-Guerra J, Guerrero-Naranjo JL, Moreno-Páramo D, Morales-Cantón V. Quiroz-Mercado H, et al. Gac Med Mex. 2008 May-Jun;144(3):245-53. Gac Med Mex. 2008. PMID: 18714594 Review. Spanish.
Bevacizumab local complications.
Gordon-Angelozzi M, Velez-Montoya R, Fromow-Guerra J, García-Aguirre G, Guerrero-Naranjo JL, Quiroz-Mercado H, Morales-Cantón V. Gordon-Angelozzi M, et al. Ophthalmology. 2009 Nov;116(11):2264.e1-3. doi: 10.1016/j.ophtha.2009.07.027. Ophthalmology. 2009. PMID: 19883862 No abstract available.
16 Gy low-voltage x-ray irradiation followed by as needed ranibizumab therapy for age-related macular degeneration: 12 month outcomes of a 'radiation-first' strategy.
Moshfeghi AA, Morales-Canton V, Quiroz-Mercado H, Velez-Montoya R, Zavala-Ayala A, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. Moshfeghi AA, et al. Br J Ophthalmol. 2012 Oct;96(10):1320-4. doi: 10.1136/bjophthalmol-2011-301222. Epub 2012 Aug 15. Br J Ophthalmol. 2012. PMID: 22895887 Clinical Trial.
16 and 24 Gy low-voltage X-ray irradiation with ranibizumab therapy for neovascular age-related macular degeneration: 12-month outcomes.
Morales-Canton V, Quiroz-Mercado H, Velez-Montoya R, Zavala-Ayala A, Moshfeghi AA, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. Morales-Canton V, et al. Am J Ophthalmol. 2013 Jun;155(6):1000-1008.e2. doi: 10.1016/j.ajo.2013.01.015. Epub 2013 Mar 14. Am J Ophthalmol. 2013. PMID: 23497847 Clinical Trial.
75 results